nach oben

Current Dermatology Reports

Erschienen in:

01.03.2015 | Epidemiology (JI Silverberg, Section Editor)

Epidemiology of Chronic Pruritus: Where Have We Been and Where Are We Going?

verfasst von: Nicholas K. Mollanazar, Savannah Dean Koch, Gil Yosipovitch

Erschienen in: Current Dermatology Reports | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Between 23 and 44 million Americans are estimated to suffer from chronic pruritus in the setting of both cutaneous and systemic conditions. Patients with chronic pruritus suffer extreme detriment to their ability to function, including but not limited to deranged sleep patterns, mood disturbances, increased levels of anxiety and depression, and reduced levels of overall quality of life. Indeed, chronic pruritus is now known to be as debilitating as chronic pain. For these reasons, chronic pruritus represents a serious public health concern that must be adequately addressed by clinicians. We present an up-to-date summary of the epidemiology of chronic itch in different cutaneous and systemic conditions. While we have endeavored to discuss some of the most common causes of chronic pruritus, this review does not encompass all of the myriad different diseases in which chronic pruritus can occur.

Ikoma A, Steinhoff M, Stander S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat Rev Neurosci. 2006;7:535–47.PubMed

2.••

Shive M, Linos E, Berger T, Wehner M, Chren MM. Itch as a patient-reported symptom in ambulatory care visits in the United States. J Am Acad Dermatol. 2013;69:550–6. This is one of the first studies to describe the impact of itch-related ambulatory care visits in the USA and the great need for continued research on the epidemiology, treatments, and potential causes of chronic itch.PubMedCentralPubMed

Matterne U, Apfelbacher CJ, Loerbroks A, Schwarzer T, Buttner M, Ofenloch R, et al. Prevalence, correlates and characteristics of chronic pruritus: a population-based cross-sectional study. Acta Derm Venereol. 2011;91:674–9.PubMed

Stander S, Schafer I, Phan NQ, Blome C, Herberger K, Heigel H, et al. Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730. Dermatology. 2010;221:229–35.PubMed

Wolkenstein P, Grob JJ, Bastuji-Garin S, Ruszczynski S, Roujeau JC, Revuz J, et al. French people and skin diseases: results of a survey using a representative sample. Arch Dermatol. 2003;139:1614–9. discussion 1619.PubMed

Stander S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A, et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol. 2007;87:291–4.PubMed

Yosipovitch G, Goon AT, Wee J, Chan YH, Zucker I, Goh CL. Itch characteristics in Chinese patients with atopic dermatitis using a new questionnaire for the assessment of pruritus. Int J Dermatol. 2002;41:212–6.PubMed

Dawn A, Papoiu AD, Chan YH, Rapp SR, Rassette N, Yosipovitch G. Itch characteristics in atopic dermatitis: results of a web-based questionnaire. Br J Dermatol. 2009;160:642–4.PubMed

O’Neill JL, Chan YH, Rapp SR, Yosipovitch G. Differences in itch characteristics between psoriasis and atopic dermatitis patients: results of a web-based questionnaire. Acta Derm Venereol. 2011;91:537–40.PubMed

10.

Dalgard F, Svensson A, Holm JO, Sundby J. Self-reported skin morbidity among adults: associations with quality of life and general health in a Norwegian survey. J Investig Dermatol Symp Proc. 2004;9:120–5.PubMed

11.

Dalgard F, Dawn AG, Yosipovitch G. Are itch and chronic pain associated in adults? Results of a large population survey in Norway. Dermatology. 2007;214:305–9.PubMed

12.

Weisshaar E, Dalgard F. Epidemiology of itch: adding to the burden of skin morbidity. Acta Derm Venereol. 2009;89:339–50.PubMed

13.

Metz M, Stander S. Chronic pruritus—pathogenesis, clinical aspects and treatment. J Eur Acad Dermatol Venereol. 2010;24:1249–60.PubMed

14.

Rea JN, Newhouse ML, Halil T. Skin disease in Lambeth. A community study of prevalence and use of medical care. Br J Prev Soc Med. 1976;30:107–14.PubMedCentralPubMed

15.

Matterne U, Strassner T, Apfelbacher CJ, Diepgen TL, Weisshaar E. Measuring the prevalence of chronic itch in the general population: development and validation of a questionnaire for use in large-scale studies. Acta Derm Venereol. 2009;89:250–6.PubMed

16.

Matterne U, Apfelbacher CJ, Vogelgsang L, Loerbroks A, Weisshaar E. Incidence and determinants of chronic pruritus: a population-based cohort study. Acta Derm Venereol. 2013;93:532–7.PubMed

17.•

Carr CW, Veledar E, Chen SC. Factors mediating the impact of chronic pruritus on quality of life. JAMA Dermatol. 2014;150:613–20. Documents the multitude of factors that influence the impact of chronic pruritus on quality of life in a large (n = 1075) cohort.PubMed

18.

Dalgard F, Lien L, Dalen I. Itch in the community: associations with psychosocial factors among adults. J Eur Acad Dermatol Venereol. 2007;21:1215–9.PubMed

19.

Sommer F, Hensen P, Bockenholt B, Metze D, Luger TA, Stander S. Underlying diseases and co-factors in patients with severe chronic pruritus: a 3-year retrospective study. Acta Derm Venereol. 2007;87:510–6.PubMed

20.•

Valdes-Rodriguez R, Mollanazar NK, Gonzalez-Muro J, Nattkemper L, Torres-Alvarez B, Lopez-Esqueda FJ, et al. Itch prevalence and characteristics in a Hispanic geriatric population: a comprehensive study using a standardized itch questionnaire. Acta Derm Venereol 2014. First study assessing the prevalence, intensity, characteristics, and associated comorbidities of chronic itch in a geriatric population.

21.

Thapa DP, Jha AK, Kharel C, Shrestha S. Dermatological problems in geriatric patients: a hospital based study. Nepal Med Coll J. 2012;14:193–5.PubMed

22.

Yalcin B, Tamer E, Toy GG, Oztas P, Hayran M, Alli N. The prevalence of skin diseases in the elderly: analysis of 4099 geriatric patients. Int J Dermatol. 2006;45:672–6.PubMed

23.

Beauregard S, Gilchrest BA. A survey of skin problems and skin care regimens in the elderly. Arch Dermatol. 1987;123:1638–43.PubMed

24.

Sayal S, Rajbhandari S, Malik A, Gupta C. A study of dermatological disorders in geriatric age group. Indian J Dermatol Venereol Leprol. 1998;64:270–2.PubMed

25.

Darjani A, Mohtasham-Amiri Z, Mohammad Amini K, Golchai J, Sadre-Eshkevari S, Alizade N. Skin disorders among elder patients in a referral center in northern Iran (2011). Dermatol Res Pract. 2013;2013:193205.PubMedCentralPubMed

26.

Rubegni P, Poggiali S, Nami N, Rubegni M, Fimiani M. Skin diseases in geriatric patients: our experience from a public skin outpatient clinic in Siena. G Ital Dermatol Venereol. 2012;147:631–6.PubMed

27.

Tey HL, Yosipovitch G. Itch in ethnic populations. Acta Derm Venereol. 2010;90:227–34.PubMed

28.

Wang H, Papoiu AD, Coghill RC, Patel T, Wang N, Yosipovitch G. Ethnic differences in pain, itch and thermal detection in response to topical capsaicin: African Americans display a notably limited hyperalgesia and neurogenic inflammation. Br J Dermatol. 2010;162:1023–9.PubMed

29.

Dalgard F, Holm JO, Svensson A, Kumar B, Sundby J. Self reported skin morbidity and ethnicity: a population-based study in a western community. BMC Dermatol. 2007;7:4.PubMedCentralPubMed

30.

Boguniewicz M. Atopic dermatitis: beyond the itch that rashes. Immunol Allergy Clin North Am. 2005;25:333–51.PubMed

31.

Wold L, Chen JK, Lampel HP. Hand dermatitis: an allergist’s nightmare. Curr Allergy Asthma Rep 2014;14:474-014-0474-0.

32.

Ruppert L, Apfelbacher C, Molin S, Bauer A, Mahler V, Schmitt J, et al. Itching in patients with chronic hand eczema: data from the CARPE registry. Dermatology. 2014;229:146–53.PubMed

33.

Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc. 2004;9:136–9.PubMed

34.

de Korte J, Sprangers MA, Mombers FM, Bos JD. Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc. 2004;9:140–7.PubMed

35.

Rapp SR, Feldman SR, Exum ML, Fleischer Jr AB, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41:401–7.PubMed

36.

van de Kerkhof PC, de Hoop D, de Korte J, Cobelens SA, Kuipers MV. Patient compliance and disease management in the treatment of psoriasis in the Netherlands. Dermatology. 2000;200:292–8.PubMed

37.

van de Kerkhof PC, de Hoop D, de Korte J, Kuipers MV. Scalp psoriasis, clinical presentations and therapeutic management. Dermatology. 1998;197:326–34.PubMed

38.

Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001;137:280–4.PubMed

39.

Szepietowski JC, Reich A, Wisnicka B. Itching in patients suffering from psoriasis. Acta Dermatovenerol Croat. 2002;10:221–6.PubMed

40.

Sampogna F, Gisondi P, Melchi CF, Amerio P, Girolomoni G, Abeni D, et al. Prevalence of symptoms experienced by patients with different clinical types of psoriasis. Br J Dermatol. 2004;151:594–9.PubMed

41.

Prignano F, Ricceri F, Pescitelli L, Lotti T. Itch in psoriasis: epidemiology, clinical aspects and treatment options. Clin Cosmet Investig Dermatol. 2009;2:9–13.PubMedCentralPubMed

42.

Yosipovitch G, Goon A, Wee J, Chan YH, Goh CL. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 2000;143:969–73.PubMed

43.

Amatya B, Wennersten G, Nordlind K. Patients’ perspective of pruritus in chronic plaque psoriasis: a questionnaire-based study. J Eur Acad Dermatol Venereol. 2008;22:822–6.PubMed

44.

Roblin D, Wickramasinghe R, Yosipovitch G. Pruritus severity in patients with psoriasis is not correlated with psoriasis disease severity. J Am Acad Dermatol;70:390–391.

45.••

Lebwohl MG, Bachelez H, Barker J, Girolomoni G, Kavanaugh A, Langley RG, et al. Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey. J Am Acad Dermatol 2014;70:871–81.e1-30. Documents the unmet needs of patients with psoriasis and highlights the need for improved severity assessment tools.

46.

Yosipovitch G, Ansari N, Goon A, Chan YH, Goh CL. Clinical characteristics of pruritus in chronic idiopathic urticaria. Br J Dermatol. 2002;147:32–6.PubMed

47.

Girardi M, Heald PW, Wilson LD. The pathogenesis of mycosis fungoides. N Engl J Med. 2004;350:1978–88.PubMed

48.

Elmer KB, George RM. Cutaneous T-cell lymphoma presenting as benign dermatoses. Am Fam Physician. 1999;59:2809–13.PubMed

49.

Bradford PT, Devesa SS, Anderson WF, Toro JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood. 2009;113:5064–73.PubMedCentralPubMed

50.

Meyer N, Paul C, Misery L. Pruritus in cutaneous T-cell lymphomas: frequent, often severe and difficult to treat. Acta Derm Venereol. 2010;90:12–7.PubMed

51.

Gerami P, Rosen S, Kuzel T, Boone SL, Guitart J. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma. Arch Dermatol. 2008;144:738–46.PubMed

52.

Duvic M, Talpur R, Ni X, Zhang C, Hazarika P, Kelly C, et al. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood. 2007;109:31–9.PubMedCentralPubMed

53.

Reich A, Welz-Kubiak K, Szepietowski JC. Pruritus differences between psoriasis and lichen planus. Acta Derm Venereol. 2011;91:605–6.PubMed

54.

Misery L, Myon E, Martin N, Verriere F, Nocera T, Taieb C. Sensitive skin in France: an epidemiological approach. Ann Dermatol Venereol. 2005;132:425–9.PubMed

55.

T-J Goon A, Yosipovitch G, Chan YH, Goh CL. Clinical characteristics of generalized idiopathic pruritus in patients from a tertiary referral center in Singapore. Int J Dermatol. 2007;46:1023–6.PubMed

56.

Nicolas ME, Krause PK, Gibson LE, Murray JA. Dermatitis herpetiformis. Int J Dermatol. 2003;42:588–600.PubMed

57.

Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation. J Am Acad Dermatol. 2011;64:1017–24. quiz 1025–6.PubMed

58.

Yeh SW, Ahmed B, Sami N, Razzaque AA. Blistering disorders: diagnosis and treatment. Dermatol Ther. 2003;16:214–23.PubMed

59.

Alonso-Llamazares J, Rogers 3rd RS, Oursler JR, Calobrisi SD. Bullous pemphigoid presenting as generalized pruritus: observations in six patients. Int J Dermatol. 1998;37:508–14.PubMed

60.

Schroder L, Hertl M, Chatzigeorgakidis E, Phan NQ, Stander S. Chronic pruritus in autoimmune dermatoses: results of a comparative survey. Hautarzt. 2012;63:558–66.PubMed

61.

Yosipovitch G, Tan A, LoSicco K, Manabat CG, Kannagra A, Carroll C, et al. A comparative study of clinical characteristics, work-up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore. Int J Dermatol. 2013;52:813–9.PubMed

62.

Shirani Z, Kucenic MJ, Carroll CL, Fleischer Jr AB, Feldman SR, Yosipovitch G, et al. Pruritus in adult dermatomyositis. Clin Exp Dermatol. 2004;29:273–6.PubMed

63.

Razykov I, Thombs BD, Hudson M, Bassel M, Baron M, Canadian Scleroderma Research Group. Prevalence and clinical correlates of pruritus in patients with systemic sclerosis. Arthritis Rheum. 2009;61:1765–70.PubMed

64.

El-Baalbaki G, Razykov I, Hudson M, Bassel M, Baron M, Thombs BD, et al. Association of pruritus with quality of life and disability in systemic sclerosis. Arthritis Care Res (Hoboken). 2010;62:1489–95.

65.

Mettang T, Kremer AE. Uremic pruritus. Kidney Int 2014.

66.

Young Jr AW, Sweeney EW, David DS, Cheigh J, Hochgelerenl EL, Sakai S, et al. Dermatologic evaluation of pruritus in patients on hemodialysis. N Y State J Med. 1973;73:2670–4.PubMed

67.

Ponticelli C, Bencini PL. Uremic pruritus: a review. Nephron. 1992;60:1–5.PubMed

68.

Pauli-Magnus C, Mikus G, Alscher DM, Kirschner T, Nagel W, Gugeler N, et al. Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. J Am Soc Nephrol. 2000;11:514–9.PubMed

69.

Narita I, Alchi B, Omori K, Sato F, Ajiro J, Saga D, et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int. 2006;69:1626–32.PubMed

70.

Pisoni RL, Wikstrom B, Elder SJ, Akizawa T, Asano Y, Keen ML, et al. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2006;21:3495–505.PubMed

71.

Zucker I, Yosipovitch G, David M, Gafter U, Boner G. Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease. J Am Acad Dermatol. 2003;49:842–6.PubMed

72.

Patel TS, Freedman BI, Yosipovitch G. An update on pruritus associated with CKD. Am J Kidney Dis. 2007;50:11–20.PubMed

73.

Yosipovitch G, Zucker I, Boner G, Gafter U, Shapira Y, David M. A questionnaire for the assessment of pruritus: validation in uremic patients. Acta Derm Venereol. 2001;81:108–11.PubMed

74.

Kremer AE, Oude Elferink RP, Beuers U. Pathophysiology and current management of pruritus in liver disease. Clin Res Hepatol Gastroenterol. 2011;35:89–97.PubMed

75.

Bergasa N. Pruritus of Cholestasis. In: Carstens E, Akiyama T, editors. Itch: mechanisms and treatment. Boca Raton (FL): by Taylor & Francis Group, LLC; 2014.

76.

Cribier B, Samain F, Vetter D, Heid E, Grosshans E. Systematic cutaneous examination in hepatitis C virus infected patients. Acta Derm Venereol. 1998;78:355–7.PubMed

77.

Koulentaki M, Ioannidou D, Stefanidou M, Maraki S, Drigiannakis I, Dimoulios P, et al. Dermatological manifestations in primary biliary cirrhosis patients: a case control study. Am J Gastroenterol. 2006;101:541–6.PubMed

78.

Huesmann M, Huesmann T, Osada N, Phan NQ, Kremer AE, Stander S. Cholestatic pruritus: a retrospective analysis on clinical characteristics and treatment response. J Dtsch Dermatol Ges. 2013;11:158–68.PubMed

79.

Stefanato CM, Reyes-Mugica M. Masked Hodgkin’s disease: the pruriginous disguise. Pediatr Hematol Oncol. 1996;13:293–4.PubMed

80.

Feiner AS, Mahmood T, Wallner SF. Prognostic importance of pruritus in Hodgkin’s disease. JAMA. 1978;240:2738–40.PubMed

81.

Gobbi PG, Attardo-Parrinello G, Lattanzio G, Rizzo SC, Ascari E. Severe pruritus should be a B-symptom in Hodgkin’s disease. Cancer. 1983;51:1934–6.PubMed

82.

Rubenstein M, Duvic M. Cutaneous manifestations of Hodgkin’s disease. Int J Dermatol. 2006;45:251–6.PubMed

83.••

Ensslin CJ, Rosen AC, Wu S, Lacouture ME. Pruritus in patients treated with targeted cancer therapies: systematic review and meta-analysis. J Am Acad Dermatol. 2013;69:708–20. Demonstrates the significant risk of pruritus in the setting of targeted anti-cancer therapies and highlights an important quality of life parameter that should be assessed in said patients.PubMedCentralPubMed

84.

Diehn F, Tefferi A. Pruritus in polycythaemia vera: prevalence, laboratory correlates and management. Br J Haematol. 2001;115:619–21.PubMed

85.

Easton P, Galbraith PR. Cimetidine treatment of pruritus in polycythemia vera. N Engl J Med. 1978;299:1134.PubMed

86.

Steinman HK, Kobza-Black A, Lotti TM, Brunetti L, Panconesi E, Greaves MW. Polycythaemia rubra vera and water-induced pruritus: blood histamine levels and cutaneous fibrinolytic activity before and after water challenge. Br J Dermatol. 1987;116:329–33.PubMed

87.

Abdel-Naser MB, Gollnick H, Orfanos CE. Aquagenic pruritus as a presenting symptom of polycythemia vera. Dermatology. 1993;187:130–3.PubMed

88.

Erskine JG, Rowan RM, Alexander JO, Sekoni GA. Pruritus as a presentation of myelomatosis. Br Med J. 1977;1:687–8.PubMedCentralPubMed

89.

Yosipovitch G. Epidemiology of itching in skin and systemic disease. In: Yosipovitch G, Greaves M, Fleischer A, McGlone F, editors. Itch: basic mechanisms and therapy. New York: Marcel Dekker; 2004. p. 183.

90.

Neilly JB, Martin A, Simpson N, MacCuish AC. Pruritus in diabetes mellitus: investigation of prevalence and correlation with diabetes control. Diabetes Care. 1986;9:273–5.PubMed

91.

Yamaoka H, Sasaki H, Yamasaki H, Ogawa K, Ohta T, Furuta H, et al. Truncal pruritus of unknown origin may be a symptom of diabetic polyneuropathy. Diabetes Care. 2010;33:150–5.PubMedCentralPubMed

92.

Chosidow O. Clinical practices. Scabies. N Engl J Med. 2006;354:1718–27.PubMed

93.

Downs AM, Harvey I, Kennedy CT. The epidemiology of head lice and scabies in the UK. Epidemiol Infect. 1999;122:471–7.PubMedCentralPubMed

94.

Walton SF, Holt DC, Currie BJ, Kemp DJ. Scabies: new future for a neglected disease. Adv Parasitol. 2004;57:309–76.PubMed

95.

Kaushik SB, Cerci FB, Miracle J, Pokharel A, Chen SC, Chan YH, et al. Chronic pruritus in HIV-positive patients in the southeastern United States: its prevalence and effect on quality of life. J Am Acad Dermatol. 2014;70:659–64.PubMed

96.

Blanes M, Belinchon I, Portilla J, Betlloch I, Reus S, Sanchez-Paya J. Pruritus in HIV-infected patients in the era of combination antiretroviral therapy: a study of its prevalence and causes. Int J STD AIDS. 2012;23:255–7.PubMed

97.

Cedeno-Laurent F, Gomez-Flores M, Mendez N, Ancer-Rodriguez J, Bryant JL, Gaspari AA, et al. New insights into HIV-1-primary skin disorders. J Int AIDS Soc 2011;14:5-2652-14-5.

98.

Josephine M, Issac E, George A, Ngole M, Albert SE. Patterns of skin manifestations and their relationships with CD4 counts among HIV/AIDS patients in Cameroon. Int J Dermatol. 2006;45:280–4.PubMed

99.

Kumarasamy N, Solomon S, Jayaker Paul SA, Venilla R, Amalraj RE. Spectrum of opportunistic infections among AIDS patients in Tamil Nadu, India. Int J STD AIDS. 1995;6:447–9.PubMed

100.

Hira SK, Wadhawan D, Kamanga J, Kavindele D, Macuacua R, Patil PS, et al. Cutaneous manifestations of human immunodeficiency virus in Lusaka, Zambia. J Am Acad Dermatol. 1988;19:451–7.PubMed

101.

Bonacini M. Pruritus in patients with chronic human immunodeficiency virus, hepatitis B and C virus infections. Dig Liver Dis. 2000;32:621–5.PubMed

102.

Oaklander AL. Neuropathic itch. In: Carstens E, Akiyama T, editors. Itch: mechanisms and treatment. Boca Raton (FL): by Taylor & Francis Group, LLC; 2014.

103.

Yosipovitch G, Samuel LS. Neuropathic and psychogenic itch. Dermatol Ther. 2008;21:32–41.PubMed

104.

Oaklander AL, Bowsher D, Galer B, Haanpaa M, Jensen MP. Herpes zoster itch: preliminary epidemiologic data. J Pain. 2003;4:338–43.PubMed

105.

Ian McDonald AC. Chapter 6—the symptoms and signs of multiple sclerosis. McAlpine’s multiple sclerosis. 4th edition ed.: Churchill Livingstone; 2005. p. 326.

106.

Elsone L, Townsend T, Mutch K, Das K, Boggild M, Nurmikko T, et al. Neuropathic pruritus (itch) in neuromyelitis optica. Mult Scler. 2013;19:475–9.PubMed

107.

Arnold LM, Auchenbach MB, McElroy SL. Psychogenic excoriation. Clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs. 2001;15:351–9.PubMed

108.

Schneider G, Driesch G, Heuft G, Evers S, Luger TA, Stander S. Psychosomatic cofactors and psychiatric comorbidity in patients with chronic itch. Clin Exp Dermatol. 2006;31:762–7.PubMed

109.

Kretzmer GE, Gelkopf M, Kretzmer G, Melamed Y. Idiopathic pruritus in psychiatric inpatients: an explorative study. Gen Hosp Psychiatry. 2008;30:344–8.PubMed

110.

Mazeh D, Melamed Y, Cholostoy A, Aharonovitzch V, Weizman A, Yosipovitch G. Itching in the psychiatric ward. Acta Derm Venereol. 2008;88:128–31.PubMed

111.

Pacan P, Grzesiak M, Reich A, Szepietowski JC. Is pruritus in depression a rare phenomenon? Acta Derm Venereol. 2009;89:109–10.PubMed

112.

Reich A, Stander S, Szepietowski JC. Drug-induced pruritus: a review. Acta Derm Venereol. 2009;89:236–44.PubMed

113.

Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA. 1986;256:3358–63.PubMed

114.

van der Linden PD, van der Lei J, Vlug AE, Stricker BH. Skin reactions to antibacterial agents in general practice. J Clin Epidemiol. 1998;51:703–8.PubMed

Titel: Epidemiology of Chronic Pruritus: Where Have We Been and Where Are We Going?
verfasst von: Nicholas K. Mollanazar
Savannah Dean Koch
Gil Yosipovitch
Publikationsdatum: 01.03.2015
Verlag: Springer US
Erschienen in: Current Dermatology Reports / Ausgabe 1/2015
Elektronische ISSN: 2162-4933
DOI: https://doi.org/10.1007/s13671-014-0093-y

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

16.04.2024 DGIM 2024 Nachrichten

Den Reflex, eine oberflächliche chronische Hautwunde ohne Entzündungszeichen in jedem Fall abzustreichen, sollte man nach einer neuen „Klug-entscheiden“-Empfehlung unterdrücken.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2015

Racial and Ethnic Disparities in Atopic Dermatitis

The Epidemiology of Vitiligo

Perspectives on Using Nanoscale Delivery Systems in Dermatological Treatment

Disease Burden Measures: a Review

Patient-Centered Outcomes in Dermatology